# Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT

> **NCT01683123** · — · COMPLETED · sponsor: **Grupo Espanol de trasplantes hematopoyeticos y terapia celular** · enrollment: 143 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Myeloproliferative Disorders
- Chronic Myeloid Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01683123
- **Lead sponsor:** Grupo Espanol de trasplantes hematopoyeticos y terapia celular
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2011-06
- **Final completion:** 2012-10
- **Target enrollment:** 143 (ACTUAL)
- **Last updated:** 2022-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01683123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01683123, "Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01683123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*